Clinical Trial Update: The Predictive Ability of 4MGS in IPF

View source ↗

Summary

The document reports on a completed clinical trial assessing how well four-meter gait speed (4MGS) predicts outcomes in idiopathic pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Snippet

Sponsor: Royal Brompton & Harefield NHS Foundation Trust | Conditions: Idiopathic Pulmonary Fibrosis | Status: COMPLETED